Giordano Christopher Thomas Insider Trades

Insider Trading History

Track insider trading activity for Giordano Christopher Thomas. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tenax Therapeutics
Tenax Therapeutics TENX
CEO
Holding Value $4.99M 450,000 shares
Last Trade
Jan 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.99M 450,000 shares
$13.30
$11.09
Tenax Therapeutics
Tenax Therapeutics TENX
CEO
Holding Value $28.9k 2,605 shares
Last Trade
Nov 20, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.08k 538 shares
$7.59
$11.09
Tenax Therapeutics
Tenax Therapeutics TENX
CEO
Holding Value $22.9k 2,067 shares
Last Trade
Nov 19, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.42k 455 shares
$7.51
$11.09
Tenax Therapeutics
Tenax Therapeutics TENX
CEO
Holding Value $17.9k 1,612 shares
Last Trade
Nov 18, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12.5k 1,612 shares
$7.75
$11.09
Tenax Therapeutics
Tenax Therapeutics TENX
CEO
Holding Value $15.5M 1,400,000 shares
Last Trade
May 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.25M 1,400,000 shares
$5.89
$11.09
Tenax Therapeutics
Tenax Therapeutics TENX
CEO
Holding Value $13.9M 1,250,000 shares
Last Trade
Dec 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.43M 1,250,000 shares
$5.94
$11.09
Tenax Therapeutics
Tenax Therapeutics TENX
CEO
Holding Value $4.85k 437 shares
Last Trade
May 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.55k 437 shares
$3.55
$11.09
Tenax Therapeutics
Tenax Therapeutics TENX
Director, CEO
Holding Value $2.22M 200,000 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$197M 200,000 shares
$984.96
$11.09

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up